Evolution of access to healthcare in Bulgaria over the last decade

15 May 2023
ema-large

The executive director of ARPharM, the Bulgarina pharma trade group, delivered the "Evolution of Access to Health in Bulgaria over the last decade" presentation at the ISPOR Bulgaria chapter and ISPOR CEE Chapter 11th Adriatic Congress on Pharmacoeconomics and Outcomes Research with Focus on CEE in Sofia.

In the past decade, access to healthcare in Bulgaria undoubtedly has improved. Public funding has doubled but remains significantly lower than the European Union (EU) average. Out-of-pocket payments are quite high. The number of hospital beds, outpatient centers, medical labs and doctors has increased. However, medical care remains unevenly distributed in the country and there is a severe shortage of nurses. Prevention and screening remain at a very low level.

Access to just 42% of EMA-approved drugs

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical